GlaxoSmithKline's experimental HIV, AIDS drug to get priority review
There are 2 comments on the San Bernardino County Sun story from Feb 19, 2013, titled GlaxoSmithKline's experimental HIV, AIDS drug to get priority review. In it, San Bernardino County Sun reports that:
U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.
Join the discussion below, or Read more at San Bernardino County Sun.
#1 Feb 19, 2013
This is an encouraging news even though nothing is still certain at least there is an action done to find a cure for HIV/AIDS.
#2 Feb 19, 2013
U.S. regulators means FDA. FDA has APPROVED every deadly and damaging Pharma product and its approval means yes Pharma you can use consumers as free test subjects for poorly tested , faulty, fraudulent product.
Add your comments below
|Ring-ring: Cellphone interrupts Supreme Court h...||Apr 25||better call Saul||1|
|Mumps outbreak probably isn't related to vaccin...||Apr 18||MMR||1|
|Bristol Palin says abstinence best path for teens (May '09)||Apr 3||Coonway Tweety||2,658|
|After Trump rally, equity investors move into h...||Mar '17||Retribution||6|
|N/R: Lack of mental, epileptic drugs hit health...||Mar '17||Humanspirit||1|
|The EpiPen debacle may be the shot heard around...||Feb '17||Suezanne||2|
|Despite $19 million salary, Mylan CEO failed to... (Sep '16)||Feb '17||Suezanne||3|
Find what you want!
Search Biotech Forum Now
Copyright © 2017 Topix LLC